Arca
Skip to content
Tools
Tools

Airsupra (albuterol and budesonide) inhalation aerosol

Recall D-0444-2025, part of FDA recall event 96857. See AsttraZeneca Pharmaceuticals's company page.

AsttraZeneca Pharmaceuticals LP started this Class II drug recall on May 14, 2025 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: May 14, 2025
  • Status: Ongoing

Why It Was Recalled

Class II

Defective delivery system

Record

Product
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .
Quantity
a) 807,837 canisters; b) 235,698 canisters
Lots and codes
Lot#: a) 6270044C00, 6270040D00, 6270034E00, Exp Date 10/2026; 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00 Exp 11/30/2026; 6270064C00, 6270071D00, 6270075D00, 6270075F00 Exp Date 12/31/2026; 6270107C00, Exp Date 9/30/2027; b) Lot 6270019E00, Exp Date 7/31/2025; 6270021D00, Exp 8/31/2025; 6270095C00, Exp 2/28/2026
Distribution
USA Nationwide
Recalling firm
AsttraZeneca Pharmaceuticals LP, Wilmington, DE, United States
How the firm notified
Letter
FDA classified
May 21, 2025

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.